⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Canara Robeco Focused Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Canara Robeco MF | HDFC MF |
| Category | Equity - Focused Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹20.40 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★ | ★★★★★ |
| Benchmark | BSE 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Shridatta Bhandwaldar | Nikhil Mathur |
| Inception | 17 May 2021 | 04 Oct 2023 |
| Returns | ||
| 1Y | -8.34% | 22.64% |
| 3Y | 12.76% | 30.41% |
| 5Y | 10.88% | — |
| Since Inception | 14.01% | 29.15% |
| Risk | ||
| 13.84 | 14.07 | |
| 0.97 | 0.59 | |
| 0.42 | 1.59 | |
| 3.46 | 21.67 | |
| 0.76 | 3.48 | |
| -12.43% | -9.23% | |
| Costs | ||
| Expense Ratio | 0.82% | 1.03% |
| Exit Load | 1% on or before 365D, Nil after 365D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹1,000 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Canara Robeco…89%
HDFC MF89%
11.3%Only 11.3% of holdings by weight are common between Canara Robeco MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingCanara Robeco MFHDFC MF
Divi's Laboratories Ltd.4.05%9.39%
Torrent Pharmaceuticals Ltd.3.86%3.65%
Max Healthcare Institute Ltd.4.49%3.61%
Category context: Equity vs Equity. Open the full Screener →